BIRC5 and cancer: Satoh et al reported that survivin was expressed in malignant portion of intraductal papillary-mucinous tumor (IPMT) but not in chronic pancreatitis, and thus proposed that survivin expression may be upregulated at an early stage of tumorigenesis by reducing cancer cell apoptosis [11].